Literature DB >> 9890982

alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration.

S Kameya1, Y Miyagoe, I Nonaka, T Ikemoto, M Endo, K Hanaoka, Y Nabeshima, S Takeda.   

Abstract

alpha1-Syntrophin is a member of the family of dystrophin-associated proteins and is strongly expressed in the sarcolemma and the neuromuscular junctions. All three syntrophin isoforms have a PDZ domain that appears to participate in protein-protein interactions at the plasma membrane. alpha1-Syntrophin has additionally been shown to associate with neuronal nitric-oxide synthase (nNOS) through PDZ domains in vitro. These observations suggest that alpha1-syntrophin may work as a modular adaptor protein that can link nNOS or other signaling enzyme to the sarcolemmal dystrophin complex. In the sarcolemma, nNOS regulates the homeostasis of reactive free radical species and may contribute to the oxidative damage to muscle protein in muscle disease such as Duchenne muscular dystrophy. In this study, we generated alpha1-syntrophin knock-out mice to clarify the interaction between alpha1-syntrophin and nNOS in the skeletal muscle. We observed that nNOS, normally expressed in the sarcolemma, was largely absent from the sarcolemma, but considerably remained in the cytosol of the knock-out mice. Even though the distribution of nNOS was altered, the knock-out mice displayed no gross histological changes in the skeletal muscle. We also discovered that muscle contractile properties have not been influenced in the knock-out mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890982     DOI: 10.1074/jbc.274.4.2193

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane.

Authors:  A S Fanning; J M Anderson
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  The dystrophin-associated glycoprotein complex: what parts can you do without?

Authors:  H L Sweeney; E R Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 3.  Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.

Authors:  Kyung-Hye Huh; Christian Fuhrer
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

Review 4.  PDZ domains-glue and guide.

Authors:  Marco van Ham; Wiljan Hendriks
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

5.  The alpha-syntrophin PH and PDZ domains scaffold acetylcholine receptors, utrophin, and neuronal nitric oxide synthase at the neuromuscular junction.

Authors:  Marvin E Adams; Kendra N E Anderson; Stanley C Froehner
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

6.  Structure of the split PH domain and distinct lipid-binding properties of the PH-PDZ supramodule of alpha-syntrophin.

Authors:  Jing Yan; Wenyu Wen; Weiguang Xu; Jia-Fu Long; Marvin E Adams; Stanley C Froehner; Mingjie Zhang
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

Review 7.  Subcellular targeting and trafficking of nitric oxide synthases.

Authors:  Stefanie Oess; Ann Icking; David Fulton; Roland Govers; Werner Müller-Esterl
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

8.  The development of the myotendinous junction. A review.

Authors:  Benjamin Charvet; Florence Ruggiero; Dominique Le Guellec
Journal:  Muscles Ligaments Tendons J       Date:  2012-09-10

Review 9.  nNOS regulation of skeletal muscle fatigue and exercise performance.

Authors:  Justin M Percival
Journal:  Biophys Rev       Date:  2011-11-08

10.  Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.

Authors:  Yoshiko Nakae; Peter J Stoward; Tatsuo Kashiyama; Masayuki Shono; Akiko Akagi; Tetsuya Matsuzaki; Ikuya Nonaka
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.